Literature DB >> 27574949

Long Noncoding RNA HOXC-AS1 Suppresses Ox-LDL-Induced Cholesterol Accumulation Through Promoting HOXC6 Expression in THP-1 Macrophages.

Chuan Huang1, Yan-Wei Hu1, Jing-Jing Zhao1, Xin Ma2, Yuan Zhang1, Feng-Xia Guo1, Chun-Min Kang1, Jing-Bo Lu3, Jian-Cheng Xiu4, Yan-Hua Sha1, Ji-Juan Gao1, Yan-Chao Wang1, Pan Li1, Bang-Ming Xu1, Lei Zheng1, Qian Wang1.   

Abstract

Atherosclerosis is a common pathological basis of cardiovascular disease, which remains the leading cause of mortality. Long noncoding RNAs (lncRNAs) are newly studied non-protein-coding RNAs involved in gene regulation, but how lncRNAs exert regulatory effect on atherosclerosis remains unclear. In this study, we found that lncRNA HOXC cluster antisense RNA 1 (HOXC-AS1) and homeobox C6 (HOXC6) were downregulated in carotid atherosclerosis by performing microarray analysis. The results were verified in atherosclerotic plaques and normal arterial intima tissues by quantitative reverse transcription PCR and western blot analysis. Lentivirus-mediated overexpression of HOXC-AS1 induced HOXC6 expression at mRNA and protein levels in THP-1 macrophages. Besides, oxidized low-density lipoprotein (Ox-LDL) decreased expression of HOXC-AS1 and HOXC6 in a time-dependent manner. Induction of cholesterol accumulation by Ox-LDL could be partly suppressed by overexpression of HOXC-AS1.

Entities:  

Keywords:  HOXC-AS1; HOXC6; Ox-LDL; cholesterol; lncRNA

Mesh:

Substances:

Year:  2016        PMID: 27574949     DOI: 10.1089/dna.2016.3422

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  19 in total

1.  SMILR Aggravates the Progression of Atherosclerosis by Sponging miR-10b-3p to Regulate KLF5 Expression.

Authors:  Huaqing Li; Zhiyu Pan; Qian Chen; Zhen Yang; Dongbing Zhang
Journal:  Inflammation       Date:  2020-10       Impact factor: 4.092

2.  Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics.

Authors:  Suowen Xu; Danielle Kamato; Peter J Little; Shinichi Nakagawa; Jaroslav Pelisek; Zheng Gen Jin
Journal:  Pharmacol Ther       Date:  2018-11-13       Impact factor: 12.310

Review 3.  Epigenetic Mechanisms in Monocytes/Macrophages Regulate Inflammation in Cardiometabolic and Vascular Disease.

Authors:  Frank M Davis; Katherine A Gallagher
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-04       Impact factor: 8.311

Review 4.  LncRNAs in vascular biology and disease.

Authors:  Viorel Simion; Stefan Haemmig; Mark W Feinberg
Journal:  Vascul Pharmacol       Date:  2018-02-06       Impact factor: 5.773

Review 5.  There and Back Again: Hox Clusters Use Both DNA Strands.

Authors:  Elena L Novikova; Milana A Kulakova
Journal:  J Dev Biol       Date:  2021-07-15

Review 6.  Functional non-coding RNAs in vascular diseases.

Authors:  Koh Ono; Takahiro Horie; Osamu Baba; Masahiro Kimura; Shuhei Tsuji; Randolph Ruiz Rodriguez; Sawa Miyagawa; Takeshi Kimura
Journal:  FEBS J       Date:  2021-01-07       Impact factor: 5.622

Review 7.  Angio-LncRs: LncRNAs that regulate angiogenesis and vascular disease.

Authors:  Bo Yu; Shusheng Wang
Journal:  Theranostics       Date:  2018-06-08       Impact factor: 11.556

Review 8.  Potential Therapeutic Targeting of lncRNAs in Cholesterol Homeostasis.

Authors:  Wen-Chu Ye; Shi-Feng Huang; Lian-Jie Hou; Hai-Jiao Long; Kai Yin; Ching Yuan Hu; Guo-Jun Zhao
Journal:  Front Cardiovasc Med       Date:  2021-06-10

9.  LncRNA BANCR facilitates vascular smooth muscle cell proliferation and migration through JNK pathway.

Authors:  He Li; Xian Liu; Lan Zhang; Xueqi Li
Journal:  Oncotarget       Date:  2017-10-07

10.  Long non-coding RNA UBE2CP3 enhances HCC cell secretion of VEGFA and promotes angiogenesis by activating ERK1/2/HIF-1α/VEGFA signalling in hepatocellular carcinoma.

Authors:  Jinduan Lin; Shunwang Cao; Yu Wang; Yanwei Hu; Hongwei Liu; Jiehua Li; Jing Chen; Pan Li; Jumei Liu; Qian Wang; Lei Zheng
Journal:  J Exp Clin Cancer Res       Date:  2018-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.